Secondary hyperparathyroidism (SHPT) affects a majority of patients with chronic kidney
disease (CKD) of stage 3 or worse. Despite the development of calcimimetics and their …

Background Despite advances in the medical management of secondary
hyperparathyroidism due to chronic renal failure and dialysis (renal hyperparathyroidism) …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. Background …

Secondary hyperparathyroidism (SHPT) is a major problem for patients with chronic kidney
disease and can cause many complications, including osteodystrophy, fractures, and …

The management of hyperparathyroidism (HPT) in the setting of familial HPT differs between
the specific syndromes and is generally complex because of the underlying disease, which …

BACKGROUND: Subtotal parathyroidectomy (SPTX) and total PTX with autotransplantation
(TPTX+ AT) are both accepted operations for secondary hyperparathyroidism (2HPT) …

Background Careful parathyroid gland dissection and in situ preservation was the time-
honored approach to prevent parathyroid failure after total thyroidectomy. The relative …

Background. Subtotal parathyroidectomy (SPTX) and total parathyroidectomy with
autotransplantation (TPTX and AT) are standard procedures in the treatment of renal …

BACKGROUND Secondary hyperparathyroidism is common in patients with end-stage
chronic kidney disease. If drug therapy fails, total parathyroidectomy with autotransplantation …

Background: Operation and reoperation for hyperparathyroidism in multiple endocrine
neoplasia type 1 (MEN 1) is controversial regarding surgical strategy, preoperative …